If you could vote on Brexit now which option would you choose?

EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot

A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 vaccine. The European Medicines Agency's (EMA) safety committee also recommended a similar warning be included for Johnson & Johnson's (JNJ.N) one-shot vaccine in October, and reiterated the decision on Friday. Transverse myelitis is an inflammation of one or both sides of the spinal cord and can cause weakness in the arms or legs, sensory symptoms or problems with bladder or bowel function.

Reuters - January 15, 2022

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/ema-lists-rare-spinal-condition-side-effect-astrazenecas-covid-19-shot-2022-01-14/